Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol KDM6B contributors: mct/npt/pgu - updated : 08-02-2022
HGNC name lysine (K)-specific demethylase 6B
HGNC id 29012
ASSOCIATED DISORDERS
corresponding disease(s) NEDCFSA
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in esophageal squamous cell carcinoma (ESCC) patients with lymph node metastasis
tumoral     --low  
in poorly differentiated high-risk neuroblastomas
tumoral     --over  
in differentiated tumors, and high KDM6B expression is prognostic for better survival in neuroblastoma patients
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
  • low KDM6B was an independent predictor of poor prognosis in surgically resected colorectal cancer (CRC) patients
  • Therapy target
    SystemTypeDisorderPubmed
    immunologyautoimmune 
    KDM6B can be a novel therapeutic target for suppressing autoimmune responses
    osteoarticularboneostéoporosis
    KDM6B may present as therapeutic targets for controlling mesenchymal stem/stromal cells (MSCs) fate choices and lead to clues for new treatment in metabolic bone diseases such as osteoporosis
    cardiovascularatheroma 
    cell-specific pharmacologic therapy targeting KDM6B may be an effective intervention for Abdominal aortic aneurysms (AAAs) expansion
    cancerdigestivecolon
    potential new therapeutic targetapproach for CRC patients
    ANIMAL & CELL MODELS
  • Jmjd3-deficient mice were resistant to the induction of experimental autoimmune encephalomyelitis (EAE)